On paper, therapeutic hypothermia after out-of-hospital cardiac arrest appears to save lives and improve neurologic outcomes at a cost comparable to other more conventional therapies, according to findings published today.
Mathematical modeling determined that hypothermia using a cooling blanket resulted in patients gaining an average of 0.66 quality-adjusted life years (QALY) (95% CI 0.11 to 1.3) compared with conventional care, wrote Raina M. Merchant, MD, of the University of Pennsylvania, and colleagues. The findings were published online in Circulation: Cardiovascular Quality and Outcomes.
The incremental cost was $31,254 (95% CI $5,581 to $77,553), resulting in an incremental cost effectiveness ratio of $47,168 (95% CI $16,673 to $191,369) per QALY.
Therapeutic hypothermia, in which the body temperature is lowered to 32° to 34°C for 12 to 24 hours, is the only postresuscitation therapy that has been shown to improve outcomes in patients with witnessed out-of-hospital cardiac arrest.
Bookmarks